CIK 0001770069
- Emerging growth company
MapLight Therapeutics, Inc.
Sign in to watch- Ticker
- MPLT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 832163243
- Phone
- +1 617-984-6300
- Business address
- 800 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063
- Former names
- Alvarado Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,256,232
- in 7 filings, $193K under 10b5-1 plans
Net −$1,256,232. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Kroeger Christopher A. −$595K Chief Executive Officer sold 6% of stake
- Hanson Kristopher −$266K General Counsel sold 17% of stake
- Foff Erin Pennock −$124K Chief Medical Officer sold 5% of stake
- Kreitzer Anatol −$96K Chief Discovery Officer sold 7% of stake
- Lillie James Woodruff −$93K Chief Scientific Officer sold 5% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-14 | Catalyst4, Inc. 10% owner | Purchase | +4,400,000 | $11.38 | $50.1M | 25,306,689 |
| 2026-08-14 | Catalyst4, Inc. 10% owner | Purchase · Warrants (right to buy) | +2,928,686 | $11.38 | $33.3M | 2,928,686 |
| 2026-07-30 | Catalyst4, Inc. 10% owner | Purchase | +1,000,000 | $13.00 | $13.0M | 20,906,689 |
| 2026-07-29 | Catalyst4, Inc. 10% owner | Purchase | +3,000 | $12.63 | $38K | 19,906,689 |
| 2026-07-28 | Catalyst4, Inc. 10% owner | Purchase | +141,088 | $10.74 | $1.5M | 19,838,552 |
| 2026-07-28 | Catalyst4, Inc. 10% owner | Purchase | +65,137 | $11.69 | $761K | 19,903,689 |
| 2025-10-28 | Catalyst4, Inc. 10% owner | Conversion | +14,256,288 | 14,256,288 | ||
| 2025-10-28 | Catalyst4, Inc. 10% owner | Purchase | +5,441,176 | $17.00 | $92.5M | 19,697,464 |
| 2025-10-28 | Catalyst4, Inc. 10% owner | Conversion · Series A Preferred Stock | −148,809 | 0 | ||
| 2025-10-28 | Catalyst4, Inc. 10% owner | Conversion · Series A-1 Preferred Stock | −444,846 | 0 | ||
| 2025-10-28 | Catalyst4, Inc. 10% owner | Conversion · Series B Preferred Stock | −1,263,768 | 0 | ||
| 2025-10-28 | Catalyst4, Inc. 10% owner | Conversion · Series B-1 Preferred Stock | −275,148 | 0 | ||
| 2025-10-28 | Catalyst4, Inc. 10% owner | Conversion · Series C Preferred Stock | −5,444,807 | 0 | ||
| 2025-10-28 | Catalyst4, Inc. 10% owner | Conversion · Series D Preferred Stock | −6,678,910 | 0 |
Page 1 of 1 · 14 trades